RT @MFT_Genomics: Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Fam…
RT @MFT_Genomics: Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Fam…
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer #Genomics #Cancer https://t.co/zFWirRFfSB
RT @ianbosdet: #HGMD inferior to random chance for assigning variant actionability https://t.co/tOgb52UipQ (Fig. S3, Maxwell 2016) https://…
RT @CaulfieldTim: Cancer gene testing = only "incremental clinical benefit" + substantial increase in complexity https://t.co/ZYDhKKLgwq @D…
RT @CaulfieldTim: Breast cancer: Study eg of how genetic testing adds more confusion than clinical benefit? https://t.co/pspQzyd6AK @Mccabe…
Breast cancer: Study eg of how genetic testing adds more confusion than clinical benefit? https://t.co/pspQzyd6AK @MccabeCJM @MccabeCJM
RT @trishgreenhalgh: In people at risk of familial cancer, extensive genetic testing only increased the noise to signal ratio. https://t.co…
Ppl at risk of familial cancer, extensive genetic testing only increased noise to signal ratio. https://t.co/EECFaN28W6 via @trishgreenhalgh
Ppl at risk of familial cancer, extensive genetic testing only increased noise to signal ratio. https://t.co/hLtBJHTeWF via @trishgreenhalgh
RT @CaulfieldTim: Cancer gene testing = only "incremental clinical benefit" + substantial increase in complexity https://t.co/ZYDhKKLgwq @D…
RT @CaulfieldTim: Cancer gene testing = only "incremental clinical benefit" + substantial increase in complexity https://t.co/ZYDhKKLgwq @D…
Cancer gene testing = only "incremental clinical benefit" + substantial increase in complexity https://t.co/ZYDhKKLgwq @DrMJoyner
RT @trishgreenhalgh: In people at risk of familial cancer, extensive genetic testing only increased the noise to signal ratio. https://t.co…
RT @trishgreenhalgh: In people at risk of familial cancer, extensive genetic testing only increased the noise to signal ratio. https://t.co…
RT @trishgreenhalgh: In people at risk of familial cancer, extensive genetic testing only increased the noise to signal ratio. https://t.co…
In people at risk of familial cancer, extensive genetic testing only increased the noise to signal ratio. https://t.co/x6sqPdlPzo
Evaluation of ACMG-Guideline-Based Variant Classification in breast cancer families https://t.co/uEUA5JzI1u
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and… https://t.co/KSsqWY8A0x #breastcancer
RT @RekaGene: @rahman_nazneen this paper from the US https://t.co/m412dFazTW echoes your talk at the @students_igmm today. More variants =…
Evaluation of ACMG-Guideline-Based Variant Classification : The American Journal of Human Genetics https://t.co/D80tgYPafM
RT @mgenomica: Aumentar los genes analizados en pacientes con cáncer de mama, más allá de variantes conocidas no añade beneficios https://…
Aumentar los genes analizados en pacientes con cáncer de mama, más allá de variantes conocidas no añade beneficios https://t.co/rnf5QLYk2Z
RT @AJHGNews: New today: Questioning the benefit of extended gene panels in screening high-risk breast/ovarian cancer families: https://t.c…
RT @AJHGNews: New today: Questioning the benefit of extended gene panels in screening high-risk breast/ovarian cancer families: https://t.c…
#HGMD inferior to random chance for assigning variant actionability https://t.co/tOgb52UipQ (Fig. S3, Maxwell 2016) https://t.co/eIRGhijmOz
RT @AJHGNews: New today: Questioning the benefit of extended gene panels in screening high-risk breast/ovarian cancer families: https://t.c…
Should larger panels/exomes still be ran on rare cancers? https://t.co/16cpSQ52mA
RT @AJHGNews: New today: Questioning the benefit of extended gene panels in screening high-risk breast/ovarian cancer families: https://t.c…
@rahman_nazneen this paper from the US https://t.co/m412dFazTW echoes your talk at the @students_igmm today. More variants = more confusion.
RT @AJHGNews: New today: Questioning the benefit of extended gene panels in screening high-risk breast/ovarian cancer families: https://t.c…
RT @AJHGNews: New today: Questioning the benefit of extended gene panels in screening high-risk breast/ovarian cancer families: https://t.c…
New today: Questioning the benefit of extended gene panels in screening high-risk breast/ovarian cancer families: https://t.co/biry7EzcAs